Atea

Atea Pharmaceuticals

This biopharmaceutical company develops oral antiviral therapies to treat patients with serious viral infections, including hepatitis C and hepatitis E.

Antios Therapeutics

This clinical-stage biopharmaceutical company develops antiviral therapies to treat and cure patients with chronic hepatitis B virus infections.

Enanta

This biotechnology company develops small molecule medicines to treat viral infections and immunological diseases for patients with serious medical conditions.

Altesa BioSciences

This company develops antiviral medicines for patients with chronic lung diseases such as COPD and asthma to prevent respiratory infections and illness flare-ups.

Dicerna Pharmaceuticals

This biopharmaceutical company develops ribonucleic acid interference therapeutics to treat rare, chronic, and infectious diseases for healthcare providers and global pharmaceutical partners.

Athira Pharma

This biopharmaceutical company develops small molecule therapies for patients with neurodegenerative conditions and certain cancers.

Arrakis Therapeutics

This biopharmaceutical company develops oral, small-molecule medicines that target RNA to treat patients with cancer, cardiovascular conditions, neurodegeneration and rare genetic diseases.

Pharmasset

This biopharma company develops medicines for patients suffering from HIV, viral hepatitis, cancer, and inflammatory diseases.